ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy.

ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy. 


April 28, 2023 — ProCure Proton Therapy Center welcomes Timothy H. Chen, MD, to a growing list of tri-state physicians with expertise in treating cancer patients with proton therapy

Dr. Chen is a board-certified radiation oncologist and Medical Director of the Central Nervous System (CNS) program at Jersey Shore University Medical Center, where he recently joined the staff. He is also the Director of Proton Therapy in the Department of Radiation Oncology at Hackensack Meridian Health, which will enable him to play a lead role in ProCure’s affiliation with Hackensack Meridian Health. ProCure entered into an affiliation with Hackensack in 2020. 

Additionally, Dr. Chen earned his medical degree from Santiago University of Technology and completed his residency in radiation oncology at New York Presbyterian Hospital - Cornell University, earning two terms as chief resident. He attended the Master of Health Care Management program at Harvard University and is fluent in Mandarin and Taiwanese. Throughout his career, Dr. Chen has delivered numerous presentations, conducted research, and contributed publications to medical literature. 

“ProCure is dedicated to increasing access to proton therapy for residents throughout New Jersey and the tri-state area,” ProCure President Tom Wang said. “Partnering with Hackensack Meridian Health and adding a physician of Dr. Chen’s credentials will help us serve more patients and potentially save more lives with this non-invasive, highly accurate treatment for cancer.” 

Unlike conventional radiation therapy, proton therapy delivers particles to the body that release most of their energy upon impact with the tumor, so there is no “exit” dose. As a result, proton therapy reduces radiation exposure of healthy tissues by more than 60 percent. Pencil Beam Scanning (PBS) is the most advanced form of proton therapy, which utilizes an ultranarrow proton beam that deposits a radiation dose more precisely within a tumor. ProCure is the first center in New Jersey to offer PBS. 

For more information: www.procure.com


Related Content

News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
News | Radiation Therapy

Sept. 25, 2025 — GE HealthCare has announced updates to Intelligent Radiation Therapy (iRT), a new version of the ...

Time September 25, 2025
arrow
News | Proton Therapy

Sept. 15, 2025 — Mevion Medical Systems announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Time September 18, 2025
arrow
News | Breast Imaging

August 18, 2025 – Akumin, a national leader in outpatient radiology and oncology services, has selected Lunit INSIGHT ...

Time August 21, 2025
arrow
News | Radiation Therapy

Aug. 12, 2025 — ZAP Surgical Systems, Inc. recently announced the treatment of the 5,000th patient using its ZAP-X ...

Time August 12, 2025
arrow
News | Advanced Visualization

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Time July 28, 2025
arrow
News | Radiology Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Time July 25, 2025
arrow
News | Radiology Imaging

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch ...

Time July 15, 2025
arrow
News | Ultrasound Imaging

July 14, 2025 — Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant ...

Time July 14, 2025
arrow
News | Lung Imaging

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate ...

Time July 10, 2025
arrow
Subscribe Now